Denali Therapeutics Inc. · NASDAQ:DNLI
Denali Therapeutics Inc. shareholders
As of Jun 30, 2026, 281 institutions reported holding Denali Therapeutics Inc., 97.7% of its shares. Largest: T. Rowe Price, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Denali Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 19.3M | 12.1% | +8.33M | Aug 14, 2026 |
| BlackRock | 14M | 8.8% | +992K | Aug 7, 2026 |
| Vanguard | 14M | 8.8% | +546K | Aug 13, 2026 |
| Baillie Gifford & Co | 12M | 7.5% | −106K | Aug 6, 2026 |
| State Street | 7.05M | 4.4% | +777K | Aug 7, 2026 |
| Temasek Holdings (Private) Ltd | 7.01M | 4.4% | no change | Aug 7, 2026 |
| UBS | 6.28M | 3.9% | −721K | Aug 13, 2026 |
| Fidelity | 4.54M | 2.8% | −39,538 | Aug 13, 2026 |
| Goldman Sachs | 4.16M | 2.6% | −251K | Aug 14, 2026 |
| Geode Capital | 3.97M | 2.5% | +246K | Aug 12, 2026 |